Certolizumab pegol in a heterogeneous population of patients with moderate-to-severe rheumatoid arthritis

AIM: To determine the efficacy and safety of certolizumab pegol for the treatment of rheumatoid arthritis in a real-world setting. MATERIALS & METHODS: Patients with moderate-to-severe rheumatoid arthritis who initiated therapy with certolizumab were followed for 12 weeks. Response was assessed...

Full description

Saved in:
Bibliographic Details
Published in:Future Sci OA
Main Authors: Soriano, Enrique R, Dellepiane, Analia, Salvatierra, Gabriela, Benítez, Cristian Alejandro, Salinas, Rodrigo Garcia, Baruzzo, Carlos
Format: Artigo
Language:Inglês
Published: Future Science Ltd 2018
Subjects:
Research Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5905631/
https://ncbi.nlm.nih.gov/pubmed/29682324
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4155/fsoa-2017-0149
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items